Cell and gene therapy investors
5 investors that name Cell and gene therapy among their sectors are recorded here: 2 corporate venture arms, 2 venture capital firms and 1 investor. Stated investment stages run from pre-seed to growth. Most are headquartered in the United Kingdom (2), Canada (1) and Sweden (1). Every fact comes from the investor’s own website and links back to the page it was read from. Coverage is incomplete and biased toward investors who publish clearly.
| Investor | Layer | Type | Stage | Headquarters |
|---|---|---|---|---|
| 4BIO Partners LLP advanced therapies · cell and gene therapy · RNA-based therapy · targeted therapies |
Direct investor | Venture capital | Seed – Series A | London, United Kingdom |
| CCRM Enterprises Holdings gene-editing technologies · gene-modified cell therapies · delivery vehicles · regenerative medicine |
Direct investor | Other | Pre-seed – Seed | Toronto, Canada |
| Delin Ventures life sciences · cell and gene therapy · drug discovery · clinical research |
Direct + LP | Corporate venture | Not stated | London, United Kingdom |
| Flerie Invest biotech · pharmaceutical · drug development · related devices |
Direct + LP | Venture capital | Pre-seed – Growth | Stockholm, Sweden |
| Sanofi Ventures Rare diseases · Immunology and inflammation · Oncology · Cell and gene therapy |
Direct investor | Corporate venture | Seed – Series C+ |